JP2020506930A5 - - Google Patents

Download PDF

Info

Publication number
JP2020506930A5
JP2020506930A5 JP2019541717A JP2019541717A JP2020506930A5 JP 2020506930 A5 JP2020506930 A5 JP 2020506930A5 JP 2019541717 A JP2019541717 A JP 2019541717A JP 2019541717 A JP2019541717 A JP 2019541717A JP 2020506930 A5 JP2020506930 A5 JP 2020506930A5
Authority
JP
Japan
Prior art keywords
betahistine
pharmaceutical composition
dose
composition according
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019541717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020506930A (ja
JP7714323B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/052695 external-priority patent/WO2018141922A1/en
Publication of JP2020506930A publication Critical patent/JP2020506930A/ja
Publication of JP2020506930A5 publication Critical patent/JP2020506930A5/ja
Priority to JP2022017792A priority Critical patent/JP2022051872A/ja
Priority to JP2024000158A priority patent/JP2024019731A/ja
Application granted granted Critical
Publication of JP7714323B2 publication Critical patent/JP7714323B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019541717A 2017-02-02 2018-02-02 ベタヒスチンを含む鼻腔内組成物 Active JP7714323B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022017792A JP2022051872A (ja) 2017-02-02 2022-02-08 ベタヒスチンを含む鼻腔内組成物
JP2024000158A JP2024019731A (ja) 2017-02-02 2024-01-04 ベタヒスチンを含む鼻腔内組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762453931P 2017-02-02 2017-02-02
US62/453,931 2017-02-02
PCT/EP2018/052695 WO2018141922A1 (en) 2017-02-02 2018-02-02 Intranasal composition comprising betahistine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022017792A Division JP2022051872A (ja) 2017-02-02 2022-02-08 ベタヒスチンを含む鼻腔内組成物

Publications (3)

Publication Number Publication Date
JP2020506930A JP2020506930A (ja) 2020-03-05
JP2020506930A5 true JP2020506930A5 (https=) 2021-03-11
JP7714323B2 JP7714323B2 (ja) 2025-07-29

Family

ID=61187302

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019541717A Active JP7714323B2 (ja) 2017-02-02 2018-02-02 ベタヒスチンを含む鼻腔内組成物
JP2022017792A Withdrawn JP2022051872A (ja) 2017-02-02 2022-02-08 ベタヒスチンを含む鼻腔内組成物
JP2024000158A Pending JP2024019731A (ja) 2017-02-02 2024-01-04 ベタヒスチンを含む鼻腔内組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022017792A Withdrawn JP2022051872A (ja) 2017-02-02 2022-02-08 ベタヒスチンを含む鼻腔内組成物
JP2024000158A Pending JP2024019731A (ja) 2017-02-02 2024-01-04 ベタヒスチンを含む鼻腔内組成物

Country Status (33)

Country Link
US (2) US10456386B2 (https=)
EP (2) EP3474850B1 (https=)
JP (3) JP7714323B2 (https=)
KR (1) KR102653545B1 (https=)
CN (2) CN118356397A (https=)
AR (1) AR111699A1 (https=)
AU (1) AU2018216970B2 (https=)
CA (1) CA3051725A1 (https=)
CL (1) CL2019002145A1 (https=)
CO (1) CO2019008657A2 (https=)
DK (2) DK3698791T3 (https=)
EA (1) EA201991817A1 (https=)
ES (2) ES2969301T3 (https=)
FI (1) FI3698791T3 (https=)
HR (2) HRP20201137T1 (https=)
HU (2) HUE065336T2 (https=)
IL (1) IL268353B2 (https=)
LT (2) LT3698791T (https=)
MA (1) MA46778B1 (https=)
MX (1) MX381932B (https=)
MY (1) MY196333A (https=)
NZ (1) NZ755931A (https=)
PH (1) PH12019501785B1 (https=)
PL (2) PL3474850T3 (https=)
PT (2) PT3474850T (https=)
RS (2) RS60554B1 (https=)
SA (1) SA519402324B1 (https=)
SG (1) SG11201906980YA (https=)
SI (2) SI3474850T1 (https=)
TN (1) TN2019000220A1 (https=)
TW (1) TWI760429B (https=)
WO (1) WO2018141922A1 (https=)
ZA (1) ZA201904955B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018170532A1 (en) * 2017-03-22 2018-09-27 Franz, Lilian Ann Treatment method
CA3179806A1 (en) * 2020-04-14 2021-10-21 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Nasal spray formulation with moisturizing benefits
JP2023523410A (ja) * 2020-04-22 2023-06-05 サノタイズ リサーチ アンド ディベロップメント コープ． 上気道感染症を治療するための組成物および方法
WO2026062705A1 (en) 2024-09-23 2026-03-26 Troikaa Pharmaceuticals Limited Oromucosal liquid compositions of betahistine or its pharmaceutically acceptable salt(s) and processes for preparation thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (https=) 1977-07-22 1981-03-20 Cherqui Jean
IT1229237B (it) * 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
JPH03287535A (ja) * 1990-03-31 1991-12-18 Bairon Boeki Kk プラノプロフェン水溶液
JP3203056B2 (ja) * 1992-08-13 2001-08-27 株式会社ティ・ティ・エス技術研究所 メシル酸ベタヒスチンの経皮吸収製剤用組成物および経皮吸収製剤
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
JPH10139667A (ja) * 1996-11-15 1998-05-26 Yoshitomi Pharmaceut Ind Ltd 水性液剤
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
JP3555598B2 (ja) 2001-06-27 2004-08-18 株式会社村田製作所 積層型インダクタ
JP2004196676A (ja) * 2002-12-16 2004-07-15 Rohto Pharmaceut Co Ltd 点鼻剤
JP4733333B2 (ja) * 2002-12-26 2011-07-27 ライオン株式会社 点鼻剤又は洗鼻剤
ATE319426T1 (de) 2003-11-11 2006-03-15 Mattern Udo Nasenformulierung mit kontrollierter freisetzung von sexualhormonen
US7728015B2 (en) * 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
AU2006202950A1 (en) * 2004-04-22 2006-10-19 Mor Research Applications Ltd. Methods and Compositions for Weight Management
JP2007533733A (ja) 2004-04-22 2007-11-22 モル リサーチ アプリケーションズ リミテッド 食物摂取管理の方法
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
WO2007022345A2 (en) * 2005-08-17 2007-02-22 Fleming And Company, Pharmaceuticals Vitamin b12 nasal spray and method of use
US8242148B2 (en) * 2005-12-23 2012-08-14 Nelson Erik B Treatment methods employing histamine H3 receptor antagonists, including betahistine
WO2007076140A2 (en) * 2005-12-23 2007-07-05 University Of Cincinnati Treatment methods employing histamine h3 receptor antagonists, including betahistine
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
BRPI0821647A2 (pt) * 2007-12-21 2015-06-16 Schering Plough Healthcare Realce da fotosestabillização de oximetazolina
EP2278999B1 (en) * 2008-04-21 2025-01-29 Dompé farmaceutici S.p.A. Auris formulations for treating otic diseases and conditions
CN102046170B (zh) * 2008-05-27 2012-11-28 墨尔本大学 治疗患有咽鼓管功能障碍的哺乳动物的方法
ES2589915T3 (es) * 2008-10-08 2016-11-17 Xgene Pharmaceutical Inc Conjugados de GABA y métodos de utilización de los mismos
US10471040B2 (en) * 2014-10-03 2019-11-12 Lachesis Biosciences Limited Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders

Similar Documents

Publication Publication Date Title
US8450339B2 (en) Compositions for treatment of common cold
AU2023202420A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
US20020193397A1 (en) Nasal delivery of apomorphine
JP2001517639A (ja) 鼻炎／結膜炎および感冒、感冒に似た症状および／または流行性感冒の症状を局所的に治療するための、鎮静作用を有しない抗ヒスタミンおよびα−アドレナリン作動薬を含む組合せ物の使用
CA2661759A1 (en) Buprenophine-wafer for drug substitution therapy
JP2020506930A5 (https=)
CN102470099A (zh) 儿童用奥洛他定鼻腔喷雾方案
CA2522291A1 (en) Nasal pharmaceutical formulations and methods of using the same
FI3698791T3 (fi) Intranasaalinen koostumus, joka käsittää betahistiiniä
CN1154495C (zh) 米氮平用于治疗睡眠性呼吸暂停的用途
WO2002024202A1 (en) Nasal delivery of apomorphine in combination with glycol derivatives
WO2010038240A9 (en) Pharmaceutical composition comprising nimesulide and levocetirizine
JP2006501211A (ja) エピナスチン、プソイドエフェドリン及びメチルエフェドリンの組み合せを含有する医薬組成物
US20090124606A1 (en) Composition for Treatment of Psychosis
US20240408003A1 (en) Compositions, devices and methods for the treatment of alcohol use disorder
AU2002329578B2 (en) Compositions for treatment of common cold
MXPA06008935A (en) Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
AU2002329578A1 (en) Compositions for treatment of common cold
HK1067984B (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
HK1092064A (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold